In a study that included tests of three types of human cancer cells, researchers report that ST6Gal-I–mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion by the cancer cells.
In a study that included tests of three types of human cancer cells, researchers report that ST6Gal-I–mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion by the cancer cells.